MUMBAI, November 18, 2014 /PRNewswire/ --
- Launch of India Pharma Market Report by UBM and Global Business Reports
- Preceded by 2nd Annual India Pharma Awards 2014
- CPhI India Technical Seminar on Industry Trends and Challenges
- +28,000 Industry Executives From +95 Countries Expected to Attend
UBM India today announced the event highlights of CPhI India, which is co-located with P-MEC India, ICSE India and BioPh and slated for 2nd-4th December 2014 at the Bombay Exhibition Centre in Mumbai, India. The three-day industry event, wherein key players of the pharmaceutical sector worldwide will congregate to connect, share and ideate, will be preceded by the India Pharma Awards, scheduled for 1st December 2014 at the Westin Hotel, Mumbai.
(Logo: http://photos.prnewswire.com/prnh/20141117/10111012 )
(Logo: http://photos.prnewswire.com/prnh/20130226/599595-c )
P-MEC India, co-located with CPhI India and in its 8th year, provides the industry with an international platform to showcase pharmaceutical equipment, machinery and technology to a forum of decision makers from across the world. Additionally, ICSE India has rapidly gained a positive reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry.
At CPhI India 2014, UBM will also release a comprehensive India pharma report, conducted with the help of research partner Global Business Reports. The report would analyse trends from leading Indian pharma players and forecast new markets and growth areas in a region predicted by analysts to reach US$45 billion by 2020.
Mr. Joji George, Managing Director, UBM India said, "Against the backdrop of India constantly seeking to match and surpass western quality standards while maintaining lower manufacturing costs, at UBM, our objective for CPhI 2014 is to help elevate India as the global pharmaceutical destination by showcasing the unique positioning of the Indian pharma market and provide an optimum investment platform amidst its global counterparts."
Recognising leading innovators across 9 categories, the India Pharma Awards initiated by UBM India acknowledge innovation and excellence in the Indian pharmaceutical industry, thus creating an industry platform to celebrate the contribution of the key players amongst their Indian and international fraternity. Against the backdrop of the global pharma industry increasingly looking at India for higher quality and low cost pharma solutions, the India Pharma Awards celebrates the thinkers and creators who consistently break new ground in the pharma sector, thereby taking the value chain to its next level. Ernst & Young is the process advisor for this prestigious event and the jury panel for 2014 India Pharma Awards is chaired by:
Reliance Commercial Finance is the event's presenting partner for the 2014 edition of the India Pharma Awards. Other partners include: airline partner - Qatar Airways, category partner- International Biotech Park and gifting partner - Giftxoxo.com.
Industry Reactions:
Mr. Sudarshan Jain, MD, Abbott Healthcare solutions: "The Indian pharmaceutical sector is clearly growing, making significant contributions to the Indian economy and putting us on the global map. This sector is redefining itself by moving to 'next practices' from 'best practices'. We see strong thrust in the manufacturing arena in line with our national priority of 'Make in India'. Some of the entries for the award clearly reflect good work done by Indian pharma industry and augurs well for the industry."
Mr. Devinder Pal, President, Catalyst Pharma Consult: "One of the key challenges faced by the industry is to reclaim the enviable reputation it had earned, which has unfortunately got tarnished... rather badly. Happily, the FDA administered jolts have done the trick - it has awakened the industry to the need of building quality culture and shunning complacency and Juggad."
Dr. Ajit Dangi, President & CEO , Danssen Consulting: "In CPhI/P- MEC, the key elements have always been innovation and excellence. Organisations are increasingly focusing on 3 p's - People, Planet and Profit and have started recruiting chief sustainability officers to give them competitive edge. The CPhI/P-MEC event will provide good insight into initiatives in this area."
About UBM India
UBM India is India's leading live media and events company that engages people and enriches businesses. UBM India provide the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content-led conferences and seminars, tech media, live events, data services and powerful media brands. UBM India hosts over 20 large scale exhibitions and 40 conferences across the country every year, thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organiser in Asia and the biggest commercial organiser in mainland China, India and Malaysia. For further details, please visit www.ubmindia.in
Primary Media Contact : Priya Badshah, [email protected], +91-9052578641, Head - PR, UBM India Pvt. Ltd.
Secondary Media Contact : Arnab Das, [email protected], +91-9167394888, Group Manager, Madison PR
Share this article